Unknown PHASE4 INTERVENTIONAL 2-arm NCT00965809

Add on Study on Δ9-THC Treatment for Posttraumatic Stress Disorders (PTSD) (THC_PTSD)

Double Blind, Placebo-Controlled Trial of THC as add-on Therapy for PTSD

Sponsor: Hadassah Medical Organization

Conditions Posttraumatic Stress Disorders

Interventions Placebo Tetrahydrocannabinol

Updated 5 times since 2017 Last updated: Oct 28, 2012 Started: Oct 31, 2009 Primary completion: Oct 31, 2012 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Posttraumatic Stress Disorders, this trial is ongoing. The trial is conducted by Hadassah Medical Organization and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hadassah Medical Organization

Data source: Hadassah Medical Organization

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jerusalem, Israel